The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope
Authors
Keywords
Sarcoma, Bone sarcoma, Soft tissue sarcoma, Next-generation sequencing, Targeted therapy, Precision oncology, Mutation, Fusion, Driver aberration
Journal
Current Oncology Reports
Volume 19, Issue 12, Pages -
Publisher
Springer Nature
Online
2017-10-13
DOI
10.1007/s11912-017-0641-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing
- (2017) Paul J Lee et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
- (2017) Suzanne George et al. IMMUNITY
- RNA sequencing validation of the Complexity INdex in SARComas prognostic signature
- (2016) Tom Lesluyes et al. EUROPEAN JOURNAL OF CANCER
- The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma
- (2016) Xiaodong Li et al. HISTOPATHOLOGY
- Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss
- (2016) Lorena Lazo de la Vega et al. HUMAN PATHOLOGY
- Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement
- (2016) Melissa D. Mathias et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion
- (2016) Vivek Subbiah et al. ONCOLOGY
- Profiling of potential driver mutations in sarcomas by targeted next generation sequencing
- (2016) Carola Andersson et al. Cancer Genetics
- The NAB2–STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing
- (2016) Natalya V. Guseva et al. Cancer Genetics
- Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies
- (2016) Vivek Subbiah et al. Scientific Reports
- Universal Genomic Testing Needed to Win the War Against Cancer
- (2016) Vivek Subbiah et al. JAMA Oncology
- Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing
- (2016) Nana Zhang et al. PLoS One
- Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives
- (2015) Monica Brenca et al. Expert Review of Anticancer Therapy
- STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
- (2015) Vivek Subbiah et al. Journal of Hematology & Oncology
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
- (2015) R. C. Doebele et al. Cancer Discovery
- Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine
- (2015) Vivek Subbiah et al. Oncotarget
- Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics
- (2014) George Jour et al. HUMAN PATHOLOGY
- Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
- (2014) Vivek Subbiah et al. Journal of Hematology & Oncology
- A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
- (2014) Shinji Kohsaka et al. NATURE GENETICS
- Recurrent PTPRB and PLCG1 mutations in angiosarcoma
- (2014) Sam Behjati et al. NATURE GENETICS
- Novel Secondary Somatic Mutations in Ewing's Sarcoma and Desmoplastic Small Round Cell Tumors
- (2014) Yunyun Jiang et al. PLoS One
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ewing sarcoma mimicking atypical carcinoid tumor: detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool
- (2014) Leona A. Doyle et al. Cancer Genetics
- Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
- (2013) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Aberrations in Imatinib-Resistant Dermatofibrosarcoma Protuberans Revealed by Whole Genome Sequencing
- (2013) Jung Yong Hong et al. PLoS One
- Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
- (2011) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started